Patient selection considerations include: Adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities [1] [7] Contraindications must be carefully reviewed, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis, gallbladder disease, severe gastrointestinal disease, or renal impairment requires caution Not recommended during pregnancy or lactation Clinicians should counsel patients that while inflammatory marker improvements have been observed in research settings, Zepbound is prescribed for weight management, not inflammation treatment
The Lancet (2021) 6
-0.92) and blood pressure
Take a breath, but go right back to it, she said, adding that GLP-1s are superior to the older drugs on the market
While tirzepatide may offer significant benefits, the cost of tirzepatide must be carefully considered by both patients and healthcare providers when evaluating treatment options
Never reuse syringes or needles